CHDN(CHDN)
CHDN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $3.03B | $3.14B | $3.25B |
| Low | $3.01B | $3.10B | $3.21B |
| High | $3.04B | $3.16B | $3.29B |
| EBITDA Avg | $1.20B | $1.25B | $1.29B |
| Low | $1.19B | $1.23B | $1.27B |
| High | $1.21B | $1.25B | $1.30B |
| EBIT Avg | $983M | $1.02B | $1.06B |
| Low | $976M | $1.01B | $1.04B |
| High | $986M | $1.02B | $1.07B |
| Net Income Avg | $497M | $539M | $527M |
| Low | $483M | $493M | $519M |
| High | $516M | $553M | $535M |
| EPS Avg | $6.97 | $7.41 | $7.40 |
| Low | $6.77 | $6.90 | $7.27 |
| High | $7.23 | $7.75 | $7.50 |
| Analysts (Rev / EPS) | 8 / 5 | 8 / 5 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $705M | $683M | $683M | $1.01B | $735M | $713M | $723M | $1.04B |
| Low | $702M | $677M | $677M | $1.00B | $728M | $707M | $717M | $1.03B |
| High | $709M | $692M | $691M | $1.02B | $744M | $722M | $732M | $1.06B |
| EBITDA Avg | $280M | $271M | $271M | $400M | $292M | $283M | $287M | $414M |
| Low | $279M | $269M | $268M | $397M | $289M | $280M | $284M | $410M |
| High | $281M | $274M | $274M | $406M | $295M | $287M | $291M | $419M |
| EBIT Avg | $229M | $222M | $222M | $327M | $238M | $231M | $235M | $338M |
| Low | $228M | $220M | $220M | $325M | $236M | $229M | $233M | $335M |
| High | $230M | $224M | $224M | $332M | $241M | $234M | $238M | $343M |
| Net Income Avg | $85M | $75M | $87M | $256M | $83M | $78M | $102M | $268M |
| Low | $83M | $75M | $86M | $253M | $82M | $77M | $101M | $265M |
| High | $87M | $77M | $88M | $260M | $85M | $79M | $104M | $272M |
| EPS Avg | $1.22 | $1.08 | $1.24 | $3.65 | $1.19 | $1.11 | $1.46 | $3.82 |
| Low | $1.19 | $1.06 | $1.22 | $3.61 | $1.17 | $1.10 | $1.44 | $3.78 |
| High | $1.24 | $1.10 | $1.26 | $3.71 | $1.21 | $1.13 | $1.48 | $3.89 |
| Analysts (Rev / EPS) | 7 / 5 | 4 / 1 | 4 / 1 | 3 / 1 | 3 / 1 | 3 / 1 | 2 / 2 | 5 / 2 |